CLINICAL_TRIALS
trial_result
· 2025-12-10
Clinical Trial Update: Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD
Summary
Post-marketing surveillance study of tolvaptan in autosomal dominant polycystic kidney disease has completed and posted its results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Polycystic Kidney, Autosomal Dominant | Status: COMPLETED | Results posted: 2025-12-10